Sélectionner la langue
Claudin-4
Claudin-4 Liste de produits
- Attribut
Protein (4)
- Bibliothèque de produits
En ligne (4)
- Espèces
Human (3)Rhesus macaque (1)
- Étiquette
His Tag & Strep Tag (2)- (2)
- Marqueur
Unconjugated (3)Biotin-labeled (1)
| Numéro de produit | Espèces | Système d'expression | Description du produit | Structure protéique | Pureté | Caractéristiques | Pré-commande/Commande |
|---|---|---|---|---|---|---|---|
CL4-H52P5 |  Human | HEK293 | Human Claudin-4 Full Length Protein (VLP) |  |  Ajouter au panier | ||
CL4-H5587 | Human | InsectCells | Human Claudin-4 Protein, His,Twin-Strep Tag (Detergent) |  |  | | Ajouter au panier |
CL4-H85D3 | Human | InsectCells | Biotinylated Human Claudin-4 Full Length Protein, Avitag™,His&Flag Tag (Detergent) |  | | | Ajouter au panier |
CL4-R5583 |  Rhesus macaque | InsectCells | Rhesus macaque Claudin-4 Protein, His,Twin-Strep Tag (Detergent) |  | | | Ajouter au panier |
Quantité totale4
- 1
Informations sur les médicaments cliniques
| Nom anglais | Code de recherche | Phase de R&D | Entreprise | Indication | Essai clinique |
|---|---|---|---|---|---|
| Cobolimab | WBP 296A; TSR-022; GSK-4069889 | Phase 3 Clinical | Anaptysbio Inc | Liver Neoplasms; Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms | Details |
| Sabatolimab | MBG-453; NVP-MBG453 | Phase 3 Clinical | Novartis Pharma Ag | Leukemia, Myelogenous, Chronic; Leukemia; Preleukemia; Hematologic Diseases; Leukemia, Myeloid; Polycythemia Vera; Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Glioblastoma; Neoplasms; Primary Myelofibrosis; Bone Marrow Diseases; Leukemia, Myeloid, Acute; Thrombocythemia, Essential | Details |
| Surzebiclimab | BGB-A425 | Phase 2 Clinical | Head and Neck Neoplasms; Squamous Cell Carcinoma of Head and Neck | Details | |
| Lomvastomig | RG-7769; RO-7121661 | Phase 2 Clinical | F. Hoffmann-La Roche Ltd | Solid tumours; Neoplasms; Small Cell Lung Carcinoma; Esophageal Squamous Cell Carcinoma; Carcinoma, Non-Small-Cell Lung; Melanoma | Details |
| BMS-986258 | ONO-7807; BMS-986258 | Phase 2 Clinical | Five Prime Therapeutics Inc, Bristol-Myers Squibb Company | Neoplasms | Details |
| Sabestomig | AZD-7789 | Phase 2 Clinical | AstraZeneca Ag | Solid tumours; Esophageal Neoplasms; Stomach Neoplasms; Hodgkin Disease; Digestive System Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Gastrointestinal Neoplasms | Details |
| S-095018 | S095018; S-095018 | Phase 2 Clinical | Servier Bio-Innovation LLC, Institut De Recherches Internationales Servier | Carcinoma, Non-Small-Cell Lung | Details |
| Anti Tim-3/CD123 CAR-T Cell Therapy(Xuzhou Medical University) | Phase 2 Clinical | Xuzhou Medical University (Xzmu), The Affiliated Hospital Of Xuzhou Medical University | Leukemia, Myeloid, Acute | Details | |
| TB-006 | TB-006; TB006 | Phase 2 Clinical | TrueBinding Inc | Autism Spectrum Disorder; Coronavirus Disease 2019 (COVID-19); Alzheimer Disease | Details |
| Verzistobart | INCAGN-02390; INCAGN-2390 | Phase 2 Clinical | Incyte Corp, Agenus Inc | Triple Negative Breast Neoplasms; Uterine Cervical Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Melanoma; Lymphoma, Follicular; Uveal melanoma; Mesothelioma; Microsatellite instability-high cancer; Small Cell Lung Carcinoma; Lymphoma, Large B-Cell, Diffuse; Ovarian Neoplasms; Carcinoma, Transitional Cell; Mismatch Repair Deficient Cancer; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Renal Cell; Carcinoma, Merkel Cell; Stomach Neoplasms; Esophageal Neoplasms; Lymphoma, B-Cell; Head and Neck Neoplasms | Details |
| BC-3402 | BC-3402 | Phase 2 Clinical | Solid tumours; Hematologic Diseases; Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Carcinoma, Hepatocellular | Details | |
| TQB-2618(Jiangsu Chia Tai-Tianqing Pharmaceutical) | TQB-2618 | Phase 2 Clinical | Solid tumours; Squamous Cell Carcinoma of Head and Neck; Myelodysplastic Syndromes; Nasopharyngeal Carcinoma; Colorectal Neoplasms; Leukemia, Myeloid, Acute; Esophageal Squamous Cell Carcinoma; Carcinoma, Squamous Cell; Lymphoma; Carcinoma, Hepatocellular; Melanoma | Details | |
| SHR-1702 | SHR-1702 | Phase 1 Clinical | Solid tumours; Myelodysplastic Syndromes; Leukemia, Myeloid, Acute | Details | |
| LY-3321367 | LY-3321367 | Phase 1 Clinical | Eli Lilly And Company | Solid tumours | Details |
| KL-A293 | KL-A293 | Phase 1 Clinical | Anyuan Pharmaceutical Technology (Shanghai) Co Ltd, Sichuan Kelun-Biotech Biopharmaceutical Co Ltd | Neoplasms | Details |
| NB-002 (Suzhou Luosheng Bio-Pharmaceutical) | NB-002 (Suzhou Luosheng Bio-Pharmaceutical); NB-002 (逻晟生物); NB-002 | Phase 1 Clinical | Solid tumours; Neoplasms | Details | |
| LPX-TI641 | LPX-TI-641 | Phase 1 Clinical | LAPIX Therapeutics Inc | Autoimmune Diseases; Multiple Sclerosis; Neuromyelitis Optica; Demyelinating Diseases | Details |
| LB-1410 | LB-1410 | Phase 1 Clinical | L&L Biopharma Co Ltd | Solid tumours; Neoplasms; Lymphoma | Details |
| Anti-PD1/anti-TIM3 bispecific antibody (L&L vision biopharmaceuticals) | Bis-5 | Phase 1 Clinical | L&L Biopharma Co Ltd | Solid tumours; Neoplasms | Details |
| LBL-003 | LBL-003 | Phase 1 Clinical | Solid tumours; Neoplasms | Details | |
| Sym-023 | Sym-023; Sym023; S95018 | Phase 1 Clinical | Symphogen A/S | Solid tumours; Lymphoma; Neoplasm Metastasis | Details |
| WBP-3425 | WBP-3425 | Phase 1 Clinical | Solid tumours; Colonic Neoplasms | Details |
- Liste de produits
- Informations sur les médicaments cliniques
Partager vers :
Message en ligne
[North America]: 1 Innovation Way, Newark, DE 19711, USA [Switzerland]: Switzerland Innovation Park Basel Area, Novartis Campus, Lichtstrasse 35, 4056 Basel
Email：order@acrobiosystems.com
Copyright © 2025 ACROBiosystems. All Rights Reserved